Ines Vaz-Luis

29PUBLICATIONS
146CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersSocial epidemiologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 26, 2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

|Mar 25, 2026
Perceived discrimination at work: examining social, health and work-related factors as determinants among breast cancer survivors - evidence from the prospective CANTO cohort.

Garazi Ruiz De Azua, Ines Vaz-Luis, Thomas Bovagnet

|Aug 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

François-Clément Bidard, Grégoire Gessain, Thomas Bachelot

|Aug 26, 2024
Evaluating the Implementation of Integrated Proactive Supportive Care Pathways in Oncology: Master Protocol for a Cohort Study.

Maria Alice Franzoi, Arnaud Pages, Loula Papageorgiou

|Aug 06, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.

Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra

|Jun 18, 2024
Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.

José Luis Sandoval, Maria Alice Franzoi, Antonio di Meglio

Pageof 5

Frequent Collaborators

13 joint publications

Barbara Pistilli

12 joint publications

Antonio Di Meglio

8 joint publications

Anne-Laure Martin

7 joint publications

Fabrice André